Expertise in
4
conditions

Zhihong H. Chi

Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
Expertise in
4
conditions
Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 

Overview

Zhihong Chi practices practicing medicine in Beijing, China.

Chi is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Melanoma, Renal Cell Carcinoma (RCC), Urothelial Cancer, Adult Soft Tissue Sarcoma, and Nephrectomy.

They are actively involved in clinical research, co-authoring 127 peer reviewed articles and participating in 1 clinical trial.

Locations

Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
Other Locations
52 Fucheng Road, Beijing, 100142, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Melanoma and Standard Treatment Failure
A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Melanoma and Standard Treatment Failure
Enrollment Status: Unknown
Publish Date: September 30, 2020
Intervention Type: Biological
Study Drug: Humanized Anti-PD-1 Monoclonal Antibody Toripalimab
Study Phase: Phase 2

127 Total Publications

Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study.
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study.
Journal: BMC medicine
Published: January 20, 2026

Frequently Asked Questions about Zhihong H. Chi

Is Zhihong H. Chi a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Zhihong H. Chi is classified as an Elite expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zhihong H. Chi participate in research or clinical trials?

Yes. Zhihong H. Chi has published 127 articles and abstracts on conditions like Melanoma. You can view a list of Zhihong H. Chi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chi's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile